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Abstract
Background: Phase-contrast magnetic resonance imaging (PC-MRI) enables quantification of cerebrospinal fluid
(CSF) flow and total cerebral blood (tCBF) flow and may be of value for the etiological diagnosis of
neurodegenerative diseases. This investigation aimed to study CSF flow and intracerebral vascular flow in patients
with Alzheimer’s disease (AD) and patients with amnesic mild cognitive impairment (a-MCI) and to compare the
results with patients with idiopathic normal pressure hydrocephalus (NPH) and with healthy elderly volunteers
(HEV).
Methods: Ten a-MCI and 9 mild AD patients were identified in a comprehensive neurological and
neuropsychological assessment. They underwent brain MRI; PC-MRI pulse sequence was performed with the
following parameters: two views per segment; flip angle: 25° for vascular flow and 20° for CSF flow; field-of-view
(FOV): 14 × 14 mm²; matrix: 256 × 128; slice thickness: 5 mm; with one excitation for exams on the 3 T machine,
and 2 excitations for the 1.5 T machine exams. Velocity (encoding) sensitization was set to 80 cm/s for the vessels
at the cervical level, 10 or 20 cm/s for the aqueduct and 5 cm/s for the cervical subarachnoid space (SAS).
Dynamic flow images were analyzed with in-house processing software. The patients’ results were compared with
those obtained for HEVs (n = 12), and for NPH patients (n = 13), using multivariate analysis.
Results: Arterial tCBF and the calculated pulsatility index were significantly greater in a-MCI patients than in HEVs.
In contrast, vascular parameters were lower in NPH patients. Cervical CSF flow analysis yielded similar values for all
four populations. Aqueductal CSF stroke volumes (in μl per cardiac cycle) were similar in HEVs (34 ± 17) and AD
patients (39 ± 18). In contrast, the aqueductal CSF was hyperdynamic in a-MCI patients (73 ± 33) and even more
so in NPH patients (167 ± 89).
Conclusion: Our preliminary data show that a-MCI patients present with high systolic arterial peak flows, which are
associated with higher mean total cerebral arterial flows. Aqueductal CSF oscillations are within normal range in
AD and higher than normal in NPH. This study provides an original dynamic vision of cerebral neurodegenerative
diseases, consistent with the vascular theory for AD, and supporting primary flow disturbances different from those
observed in NPH.
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Although the exact frequencies of different types of
dementia are still difficult to assess, Alzheimer’s disease
(AD) is the most common subtype and idiopathic normal
pressure hydrocephalus (NPH) is rare [1]. Subtle losses of
cognitive function (particularly memory complaints, con-
trasting with preserved daily living activities), can result
from normal ageing but may also represent a transitional
state to early AD and are frequently referred to as amne-
sic mild cognitive impairment (a-MCI) [2]. Although the
reported prevalence of a-MCI varies from one study to
another partly as a result of different evaluation criteria,
this condition is now recognized as a risk factor for AD.
T h ea n n u a lc o n v e r s i o nr a t ef r o ma - M C It oA Di se s t i -
mated between 10 and 15%, compared with 1 to 2% seen
in healthy, non -impaired control subjects [2].
Clinicians routinely use morphological brain imaging
especially magnetic resonance imaging (MRI), to study
etiologies and assist with differential diagnosis in patients
with cognitive disorders. These conventional techniques
have revealed various degrees of ventricular dilation, with
global or localized cerebral atrophy. In some patients,
cerebral and/or ventricular dilation may be difficult to
relate to any of the various etiologies considered. Even
though the cortical atrophy observed in AD patients
occurs in a defined sequence which is increasingly well
understood [3], it remains the case that volume loss
detected on MRI is related to the extent of neuron loss
[4]. Thus, it may be difficult to distinguish age-related
atrophy from atrophy caused by mild AD.
In normal ageing, the overall volume of the brain com-
partment falls slightly. However, this atrophy is signifi-
cantly greater in patients with AD - by up to 25 or 50%,
depending on the severity of the disease. The atrophy
predominates in the temporal regions and especially in
the hippocampus [5,6]. Recent publications have sug-
gested similar local atrophy in MCI patients [6] and long-
itudinal studies have emphasized the potential value of
rapid temporal volume changes in predicting conversion
from MCI to AD [4,7]. In contrast, NPH is typically asso-
ciated with ventricular dilation far in excess of that
expected from cortical atrophy.
Several techniques have been used to study the effects
of normal ageing on vascular flow. Low global cerebral
blood flow in the elderly has been variously reported by
studies using sonography [8], positron emission tomogra-
phy (PET) [9], angiographic MRI [10,11] and, more
recently, phase contrast (PC)-MRI [12,13]. Metabolic stu-
dies suggest the presence of vascular modifications in AD
patients and in a-MCI patients who will convert to AD
[13,14]. Similarly, a role for vascular flow in the patho-
genesis of NPH has been suggested in the last decade,
initially with an emphasis on the involvement of ischemia
of the deep white matter [15]. The major role of venous
circulation in the regulation of intracerebral dynamics
has been defended by other authors [16] and has recently
led to the “venous hypothesis of NPH” [17], in which
venous dysfunction is presumed to be a crucial initiating
factor for hydrocephalus.
New theories have suggested that senescence of the
CSF circulatory system may contribute to the pathogen-
esis of neurodegenerative diseases [18] and that there
may be a metabolic and neuropathological continuum
which parallels the observed clinical overlap. Morpholo-
gical studies have shown structural alterations of the
choroid plexuses in AD patients, with reduced CSF secre-
tion of proteins [19]. Although it has been suggested that
these structural and metabolic modifications induce
dynamic alterations in the intracranial fluids, the few stu-
dies that have investigated (at least in part) these features
have generally featured small populations [20,21]. Some
authors further suggest that AD is related to a dramatic
decrease in CSF production, which slows beta amyloid
(Ab) clearance, increases Ab deposition in the meninges
and thus raises the resistance to CSF outflow [22,23]. In a
randomized, controlled pilot study [24], the same authors
suggested that there is a subgroup of “hybrid” AD-NPH
patients who meet the clinical criteria for AD and also
have elevated CSF pressure suggesting early-stage hydro-
cephalus. Thus, the clinical overlap between these etiolo-
gies and the presence of AD-like neuropathological
features in NPH patients varying from 27 to 75%, [25,26]
depending on the severity of dementia, suggest a com-
mon physiological basis for CSF circulatory failure - an
effect which is far greater than the decrease in turnover
observed during normal ageing.
A recent study [12] in healthy elderly volunteers
(HEVs) showed lower pulsatility in CSF oscillations in
both ventricular and subarachnoid compartments, when
compared to healthy young volunteers; this contrasts
with the hyperdynamic aqueductal CSF oscillations
widely described in NPH patients [21,27,28]. In the pre-
sent study, we set out to compare CSF flow and cerebral
blood flow in a-MCI and AD patients, compared to
NPH patients and HEVs, with the aim of developing
tools for use in differential diagnosis.
Materials and methods
Participants
Patients were recruited from our hospital’s Alzheimer’s
disease patient registry and research centre. At baseline,
all patients met the criteria for a-MCI or AD. Patients
were categorized in a special consultation with a neurol-
ogist and a neuropsychologist. Dementia and AD were
diagnosed according to the DSM-IV and NINCDS-
ADRDA criteria [29], respectively. We selected patients
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Examination (MMSE) [30] score ≥ 20 out of 30. The
diagnostic criteria for elderly patients with a-MCI were
those published by Petersen et al.[ 2 ] :( i )as u b j e c t i v e
memory complaint (i.e. reported by the patient or by his
family), (ii) a documented, objective memory impair-
ment adjusted for age and education, (iii) relatively nor-
mal general cognitive function, (iv) no dementia
according to the DSM-IV criteria, and (v) generally pre-
served activities of daily living. Patients with a relevant
neurological disease (stroke, tumour, etc.) or cerebrovas-
cular risk factors (except for arterial hypertension con-
trolled by medication) were not included in the study.
The third (NPH) group consisted of age-matched
patients presenting with 2 or 3 of the Hakim triad
symptoms (gait troubles were mandatory) with an insi-
dious onset, no antecedent events such as head trauma,
intracerebral haemorrhage or meningitis or other known
cause of secondary hydrocephalus, ventricular enlarge-
ment on brain MRI (Evan’s ratio > 0.3) and no macro-
scopic signs of obstruction to CSF flow. Based on these
criteria and published guidelines [31], patients were clas-
sified as having “possible” NPH and the diagnosis was
confirmed by specialist neurosurgical consultation and
positive tap tests.
Hence, our patient populations consisted of 10 a-MCI
patients (mean ± standard deviation (SD) age: 78 ± 7
years), 9 AD patients (mean ± SD age: 79 ± 5 years) and
13 NPH patients (mean ± SD age: 70 ± 6 years). The
groups’ demographic data and MMSE scores are sum-
marized and compared in Table 1. All patients under-
went the same PC-MRI imaging protocol. The patients
were compared with a population (n = 12) of age-
matched HEVs (mean ± SD age: 71 ± 9 years) with
normal neurological and neuropsychological screening
results (notably a normal MMSE score for educational
level) and no active psychiatric, neurological or cognitive
disorders.
The study protocol was approved by the local inde-
pendent ethics committee. All participants had received
an explanation of the study’s objectives and procedures
and provided their written informed consent to
participation.
Data acquisition
All MRI exams were performed with a standardized ima-
ging protocol on a 1.5 or 3 Tesla (T) machine (Signa;
General Electric Medical System, Milwaukee, WI, USA).
Flow images were acquired with a 2 D fast cine PC-MRI
p u l s es e q u e n c ew i t hr e t r o s p ective peripheral gating, so
that the 32 analyzed frames covered the entire cardiac
cycle (CC). The MRI parameters were as follows: 2 views
per segment; flip angle: 25° for vascular flow and 20° for
CSF flow; field-of-view (FOV): 14 × 14 mm²; matrix:
256 × 128; slice thickness: 5 mm; one excitation for the
3 T machine and two for the 1.5 T machine. Velocity
(encoding) sensitization was set to 80 cm/s for the ves-
sels, 10 or 20 cm/s for the aqueduct and 5 cm/s for the
cervical subarachnoid space (SAS). A sagittal scout view
was used as a localizer to select the anatomical levels for
flow quantification. The selected acquisition planes were
perpendicular to the presumed flow direction. Sections
for each flow series are presented in Figure 1. The acqui-
sition time for each flow series was about 90 s on the 3 T
Table 1 Demographic data and results for vascular and CSF flows in four groups
Characteristic HEVs aMCI AD NPH P-value
Number of subjects 12 10 9 13 NS
Age (years) 7 1±9 7 8±7 7 9±5 7 0±6 NS
Disease duration (months) / 27 ± 18 29 ± 11.4 24 ± 15 NS
MMSE 29 ± 2 26 ± 3 21 ± 3 ND <0.05
BPM 78 ± 10 65 ± 8 72 ± 8 73 ± 15 NS
tCBF (ml/min) 509 ± 108 638 ± 126 560 ± 83 450 ± 129 <0.01
API 59 ± 12 119 ± 69 107 ± 50 93 ± 42 <0.05
Arterial pulse volume (ml) 0.8 ± 0.3 1.4 ± 0.4 1 ± 0.3 0.8 ± 0.4 <0.01
VBF (ml/min) 367 ± 130 522 ± 157 457 ± 71 361 ± 92 0.01
AV stroke volume (ml/CC) 0.7 ± 0.3 1.3 ± 0.3 1 ± 0.5 0.9 ± 0.4 0.01
AV delay (% of CC) 18 ± 6 12 ± 6 8 ± 7 10 ± 4 <0.01
Cervical stroke volume (μl/CC) 457 ± 154 584 ± 152 450 ± 221 455 ± 133 NS
Aqueductal stroke volume (μl/CC) 34 ± 17 73 ± 33 39 ± 18 167 ± 89 <0.01
Results are given for four groups: (i) healthy elderly volunteers (HEVs) and patients with (ii) amnesic mild cognitive impairment (a-MCI), (iii) Alzheimer’s disease
(AD) and (iv) normal pressure hydrocephalus (NPH). Values are expressed as the mean ± standard deviation. MMSE: Mini Mental State Examination; BPM: heart
rate in beats per minute; tCBF: total cerebral arterial blood flow; API: arterial pulsatility index; VBF: venous blood flow; AV: arteriovenous; ml: millilitre; μl:
microlitre; min: minute; CC: cardiac cycle.
The threshold for statistical significance was set to p < 0.05; NS: not significant.
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iations that depended on the participant’s heart rate. The
total, additional examination time for these CSF and
blood flow investigations was around 10 min.
Data analysis
Data were analyzed using in-house image processing soft-
ware http://www.tidam.fr. An optimized CSF and blood
flow segmentation algorithm was used to automatically
extract the region of interest (ROI) at each level. The
R O I s( F i g u r e1 )c o n s i d e r e dh e r ew e r et h er i g h ta n dl e f t
internal carotid arteries (ICAs), vertebral arteries (VAs),
internal jugular veins (IJVs) and epidural veins (EVs) (for
blood flows) and the aqueductal and cervical (C2-C3)
areas (for CSF flows). In each ROI, flows were calculated
for each of the 32 time frames in order to build a flow
curve over the course of the CC. Flows in the ICA and
VA on the left and right sides were summed to generate
the total arterial cerebral blood flow (tCBF). We also cal-
culated an arterial pulsatility index (API), which corre-
sponded to the slope of the flow curve over time. We
first measured the maximum and minimum flow ampli-
tudes (Fmax and Fmin, respectively, expressed in ml/min)
and their times of occurrence (Tmax and Tmin, respec-
tively, expressed in milliseconds). The API index was
then calculated as follows: API = (Fmax -F min)/(Tmin -
Tmax)/2, and is represented in Figure 2.
We also used these parameters (Fmax -F min and Tmin
-T max) to calculate the arterial volume pulsed at
the beginning of systole, which is expressed as follows
(in ml):
Arterial pulse volume = (Fmax -F min)×( T min -T max).
Similarly, the cervical venous blood flow (VBF) was cal-
culated by summing the venous flows in the left and
right IJVs and EVs. A correction factor was applied to
the amplitude of the internal jugular flow so that the
mean total inflow arterial rate equalled the mean total
outflow venous rate. The difference in total arterial and
total venous flows over a CC corresponds to the arterio-
venous (AV) curve, which is shown in Figure 2. After
integration, the area under the curve represents the AV
stroke volume (SV) and corresponds to the total blood
volume mobilized in either caudal (output) or cranial
(input) directions during the CC. In addition, we calcu-
lated the cervical arteriovenous delay (AVD), which cor-
r e s p o n d st ot h et i m ed i f f e r e n c eb e t w e e nt h ea r t e r i a l
systolic maximum flow peak (in the ICA) and the
venous maximum peak (in the IJV). The AVD is
expressed in milliseconds or as a percentage of the CC.
Lastly, analysis of the CSF flow curves at aqueductal and
cervical levels yielded the CSF SVs, which represent the
oscillatory CSF volume displaced in both directions
through the given ROI at each level [32].
An additional file presents cerebral flows animation
(Additional file 1. 3-D global animation of CSF and cer-
ebral vascular flows). This video of an NPH patient was
created by merging PC-MRI data sets with morphologi-
cal MR images. It shows animated CSF/blood flows
through the aqueduct of Sylvius, the C2-C3 subarach-
noid spaces, the internal and vertebral carotid arteries
and the jugular veins during the cardiac cycle.
Statistical analysis
Comparison of CSF and blood flow parameters in the
four groups (AD, a-MCI and NPH patients and HEVs)
was based on standard analysis of variance (ANOVA)
for parametric data (tCBF, VBF, AVD, AV SV and cervi-
cal SV) and a Kruskal-Wallis one-way ANOVA on ranks
for non-parametric data (API and aqueductal SV). When
the ANOVA result achieved statistical significance, Bon-
ferroni post-hoc analysis was used to identify the signifi-
cantly different groups. The threshold for statistical
significance was set to 0.05.
Results
Flow results for the arterial, venous and CSF compart-
ments in the four groups are summarized in Table 1
Figure 1 Data acquisition by phase-contrast magnetic
resonance imaging. Sagittal scout view sequences were used as
localizers to select the anatomical levels for flow quantification. The
selected acquisition planes were perpendicular to the presumed flow
direction. Sections through the aqueduct of Sylvius (a) and the C2-C3
subarachnoid space (b) were used for CSF flow measurement. By
varying the velocity encoding, the same cervical section level (c) was
used to measure vascular flows in the left and right internal carotid
arteries (ICAs), vertebral arteries (VAs), internal jugular veins (IJVs) and
epidural veins (EVs). Figures 1(a), (b) and (c) represent the flow
acquisition over the cardiac cycle. See also additional file: Movie1 for
the original data used to perform this analysis’.
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in Table 2.
The mean arterial (tCBF) flow curves for each of the
four populations are shown in Figure 3.
Vascular flow in a-MCI patients showed significant
differences when compared with HEVs, with greater
mean arterial and venous flow and a greater AV SV.
Similarly, we observed hyperdynamic arterial flow as
represented by the sharp peak seen in Figure 3. This
finding was confirmed by the significantly elevated API
and arterial pulse volume found in a-MCI patients.
Although the aqueductal CSF SV was much greater in
a-MCI patients than in HEVs, the difference did not
achieve statistical significance. This was also the case for
the cervical CSF SV, despite higher values than in the
other three groups.
In AD patients, vascular flow was greater than in
HEVs and NPH patients but was less dynamic than in
a-MCI patients. The latter difference did not achieve
statistical significance (Table 2). The ventricular CSF SV
was similar to that seen in HEVs; hence, AD patients
did not show the elevated aqueductal CSF oscillation
observed in a-MCI patients. In contrast, NPH patients
showed lower mean arterial and venous flows. These
values did not differ significantly from those recorded in
HEVs but were significantly lower than those observed
in a-MCI patients. The ventricular CSF SV was higher
in NPH patients than in all of the other groups and this
Table 2 Post hoc comparisons of vascular and CSF flow results in the four groups
HEVs vs. aMCI HEVs vs. AD HEVs vs. NPH aMCI vs. AD aMCI vs. NPH AD vs. NPH
tCBF 0.01 NS NS NS <0.01 0.06
API <0.05 NS NS NS NS NS
Arterial pulse volume <0.01 NS NS 0.06 <0.01 NS
VBF <0.01 NS NS NS <0.01 NS
AV stroke volume <0.01 NS NS NS 0.05 NS
AV delay <0.01 <0.01 <0.01 NS NS NS
Aqueductal stroke volume NS NS <0.05 NS NS <0.05
HEVs: Healthy elderly volunteers; aMCI: patients with amnesic mild cognitive impairment; AD: patients with Alzheimer’s disease; NPH: patients with normal
pressure hydrocephalus; tCBF: total cerebral arterial blood flow; API: arterial pulsatility index; VBF: venous blood flow; AV: arteriovenous. P values in bold are
statistically significant. P values on a grey background are close to statistical significance. NS: not significant.
Figure 2 Vascular arterial, venous and arteriovenous flow curves . Mean arterial, venous and arteriovenous flows are represented over two
successive cardiac cycles (CC) in one patient. The arterial blood flow peaks and troughs are represented. The difference in amplitude (ΔF=F max -F min)
and latency ((ΔT=T min -T max) between these 2 features is also shown. The arterial pulsatility index (defined as ΔF/ΔT) corresponds to the slope of the
arterial flow curve at the beginning of systole. The arterial pulse volume (defined as ΔF×ΔT/2) corresponds to the systolic arterial inflow volume. The
arteriovenous flow curve results from the difference between the arterial and the venous flow curves over a given CC. Integration of the area under
the curve yields the arteriovenous stroke volume, which represents the volume blood carried into the cranium (the input cerebral blood volume) or
expulsed caudally (the output cerebral blood volume) from the cranium over the course of the CC. The difference in latency between the arterial and
venous flow peaks (in milliseconds or as a percentage of the CC) corresponds to the arteriovenous delay (AVD).
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ing NPH patients with HEVs and to AD patients.
Although both a-MCI and NPH patients showed a
lower than normal AVD, the two groups could be differ-
entiated on the basis of vascular data: a-MCI patients
had hyperdynamic arterial and venous flows, whereas
NPH patients had lower mean arterial and venous flows
and less arterial pulsatility. Finally, the AVD was signifi-
cantly lower in all patient groups than in HEVs.
Discussion
Several authors [27,33-35] have suggested that cerebral
atrophy or hydrocephalus can be induced by an imbal-
ance in the interaction between three intracranial com-
partments: the brain parenchyma, the ventricular and
subarachnoid CSF and the vascular tree (which extends
from the arteries to the venous system and includes the
capillary vasculature) (Figure 4). These three compart-
ments are supposedly incompressible in steady physiolo-
gical states and the adult cranium is usually considered
as a rigid, closed box. As such, these systems are gov-
erned by the Monro-Kellie doctrine, which states that
any volume increase in one compartment should be
compensated by the withdrawal of an equal volume in
one of the other two compartments, in order to main-
tain a steady intracranial pressure (ICP) [34,36,37].
Hence, each of these compartments can be character-
ized by its compliance - an indicator of distensibility,
which corresponds to the pressure increase that occurs
in the system when a volume is added to it.
To a certain extent, this pressure equilibrium is threa-
tened at the beginning of each systole, when a high
volume of blood is carried into the cranium
(corresponding to the arterial pulse volume). A rapidly
movable volume should therefore exit the cranium; this
represents the “total cranial mobile compliance”,t h er o l e
of which is to avoid irreversible brain damage [36,37].
Thus, transmission of the pressure wave from the arterial
tree to the venous tree is responsible for displacing con-
secutive volumes from the cranium. This pressure wave
transmission is expressed by the AVD and is related to
the total cranial mobile compliance [16].
A previous study [12] reported that young and elderly
healthy adults have similar AVDs and thus suggested that
normal ageing is not associated with a change in total
intracranial compliance. In this previous work, PC-MRI
revealed that normal ageing is associated with a signifi-
cant reduction of total arterial blood flow and of the
Figure 4 The dynamic interaction between the intracranial
compartments. At the start of systole, an arterial volume suddenly
flows into the cranium. This causes an immediate increase in the
intracranial pressure (ICP). According to the Monro-Kellie doctrine,
this increase in ICP is countered by a succession of flush flows
through the venous and CSF compartments. The temporal
coordination of these flush flows is now well documented and is
organized according to the venous and CSF viscosities and flow
resistances and brain compliance. The arterial peak flow (1) is first
transmitted to the cervical CSF flow (2), the venous blood flow
(3) and, lastly, the ventricular CSF flow (4).
Figure 3 Arterial flow curves in the three groups of patients
and in healthy volunteers. The mean arterial flow curve is plotted
for each of the four populations over two successive cardiac cycles.
In order to simplify the figure, the standard deviations have been
intentionally omitted. The flow scale increases from top to bottom.
Note the sharper, higher systolic arterial peak in MCI and (to a lesser
extent) in AD patients, when compared with healthy elderly
volunteers (HEVs) and NPH patients. There were significant
differences between these curves (please refer to the values
reported in Tables 1 and 2).
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venous flow. Interestingly, in the same study [12], both
cervical and aqueductal CSF SVs were reduced in the
elderly subjects, with a constant ratio, suggesting a pro-
portional loss of compliance in these two compartments.
In the current study, patients with neurodegenerative
diseases showed a significantly lower AVD (and thus
total intracranial compliance) than HEVs. There were no
significant differences between the three etiologies. These
findings suggest that a-MCI, AD and NPH are probably
associated with an imbalance in the dynamic interaction
between vascular and CSF compartments. In a-MCI and
AD, this imbalance seems to be provoked by abnormal
hyperdynamic arterial input, which is dampened to some
extent by the venous and CSF regulatory systems. How-
ever, our calculations in a-MCI and AD patients did not
take account of the brain parenchyma compliance, which
may be more impaired here than in primary dynamic dis-
orders like NPH. In contrast, NPH is characterized by
primary defects in the regulatory compartments (the
intracranial CSF) and, unsurprisingly, the loss of intracra-
nial compliance is evidenced by a change in the AVD.
The arterial theory of pre-demential MCI and AD states
In patients with clinically defined a-MCI, arterial
mean flows were significantly higher than in HEVs. The
a-MCI patients also showed a much higher API (mea-
suring the slope of the rise in arterial flow at the begin-
ning of systole), which was consistent with the
calculated arterial pulse volume (i.e. the arterial blood
volume displaced in early systole). These changes in vas-
cular dynamics may be correlated with the data on the
prevalence of hypertension or other cardiovascular risk
factors collected on inclusion. We observed mild dia-
betes in one a-MCI patient and similar proportions of
arterial hypertension in the four study groups. Further-
more, all patients and healthy volunteers were only
included in the study if their hypertension was medically
controlled. Additionally, the a-MCI patients had a lower
average heart rate than HEVs, although the difference
was not statistically significant, contrasting with the
higher arterial blood flow in a-MCI patients (Table 1).
These results argue in favour of a change in the regula-
tion of the arterial input (pumped by the heart) in a-
MCI patients. An alternative explanation would relate to
white matter vascular alterations. Although this para-
meter was not strictly quantified in the present study,
no differences were readily apparent in a visual analysis.
In the absence of confounding parameters, our results
suggest that a-MCI predemential states (even those
without prominent leukoaraiosis) display a significantly
elevated arterial cerebral inflow. These results are con-
cordant with previous studies in which AD patients
s h o w e dah i g hp r e v a l e n c eo fr i s kf a c t o r sf o r
atherosclerosis, supporting the hypothesis that AD is “a
vascular disease” [38]. Anatomopathological studies have
shown Ab deposition in the leptomeningeal arteries in
AD patients [39] and capillary wall disruption is consis-
tently found [40]. Thus, it seems that increased artery
pulsation results in regular dilation and then recoil, driv-
ing the interstitial fluid and proteins in the opposite
direction to blood flow. The subsequent accumulation
of Ab in the brain’s perivascular interstitial fluid drai-
nage pathways could theoretically be responsible for the
observed cortical deposits and clinical signs of AD.
The dynamic consequences of this theory have already
been investigated in patients with AD. Two studies
[41,42] used transcranial Doppler ultrasound to evidence
increased intracranial arterial pulsatility in AD patients
(1.07 and 0.92), when compared with published refer-
ence data (a value of 0.83) [41]. Thus, it seems that the
high extracranial arterial pulsatility demonstrated in our
study in patients with neurodegenerative disease is
transmitted (at least part) to the intracranial vascular
compartment (where it can be detected in the basal
arteries by using Doppler ultrasound). Elevated extracra-
nial arterial pulsatility has also been suggested by MRI
studies; Uftring [21] used mathematical transfer func-
tions to compare the mechanical coupling of vascular
and CSF flow oscillations in normal elderly subjects and
AD patients. In both groups, there was a tendency for
elevated vascular pulsations to cause elevated spinal
cord oscillations and reduced subarachnoid CSF oscilla-
tions. The amplitude of these changes was greater in
AD patients than in normal elderly subjects. Even
though Barkhof [33] did not find any changes in vascu-
lar or CSF flows in the elderly, we have previously
shown [12] that normal ageing is associated with a sig-
nificant fall in cerebral blood flow and in the pulsatility
of the arterial input, as evidenced by a smoother systolic
inflow peak than in young adults.
Therefore, our results suggest that a-MCI is associated
with an abnormally high arterial pulsatility (indepen-
dently of white matter abnormalities), which is probably
due to degenerative changes in the arterial walls. These
hyperdynamic arterial oscillations result in increased
pulsatility at the aqueductal level. Indeed, the ventricular
CSF SV was higher in a-MCI patients than in HEVs
(although the difference did not achieve statistical signif-
icance); this is probably a reaction to arterial pulsatility
and an attempt to dampen the increase in intracranial
pressure.
Our results also revealed greater arterial pulsatility in
AD patients, although the difference versus the other
groups was not statistically significant. This change may
be due to progression of arterial hyperdynamism during
the transition from a-MCI to AD and a corresponding,
steady reduction of cerebral compliance until a plateau
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nied by relevant cerebral atrophy and a proportional
decrease in energy needs and thus arterial perfusion.
However, the establishment of this hypothesis is ham-
pered by the small size of our groups and needs to be
confirmed in larger populations.
Differential diagnosis for NPH
The vascular results enabled us to discriminate between
a-MCI and NPH patients, since the latter had signifi-
cantly lower arterial flows and pulsatility indexes. In con-
trast, previously published data [43] have not found
arterial pulsation or the aqueductal SV to be of value in
differentiating between AD and NPH patients. This dis-
crepancy may be related to differences in selection cri-
teria (i.e. pre-demential a-MCI in our study and patients
with advanced AD in Bateman’s study). Nevertheless, our
results indicate that NPH and AD-like neurodegenerative
diseases are probably caused by different etiological
mechanisms. As mentioned above, we believe that arter-
ial input may be the prime factor in the dynamic modifi-
cations seen in a-MCI; this would result in hyperdynamic
functioning of the CSF and venous compartments and a
moderate increase in ventricular CSF oscillation. In NPH
patients, our results show low arterial pulsation and
greatly elevated ventricular CSF oscillation.
In normal subjects, increased intracerebral volume
usually caused by systolic arterial inflow, results in
expansion of the arterial tree in two directions: (i) out-
ward from the ventricles (with associated outward brain
compression and CSF flush flow through the SASs) and
(ii) inwards due to ventricle compression and aqueductal
CSF flush flow. The elevated arterial inflow in a-MCI
patients means that the arteries would essentially
expand outward from the ventricles; this would result in
greater expansion of the outer portion of the brain and
subarachnoid CSF dampening of the pulse pressure. The
inward compression of ventricles is moderate and so the
aqueductal SV is not greatly elevated.
In NPH, the primary defect has been linked to a
decrease in CSF oscillation [27] (and thus compliance) in
the cerebral SAS [20] as a result of the compression of
cortical venous drainage. Indeed, increased pressures in
the cranial sinuses have been demonstrated in animal
studies [44]. Reduced CSF absorption in the venous dural
sinuses then results in an inward compression of the ven-
tricles and a greater aqueductal SV. The arterial flow
reduction seems to be a secondary feature. If this distur-
bance were to persist, the ventricular system compliance
would be overloaded and ventricle dilation would occur.
The role of aqueductal CSF flow
When comparing the four groups, NPH patients had a
significant greater aqueductal SV than the HEVs and AD
patients. Previous studies have suggested the usefulness
of aqueductal oscillations as a helpful tool for diagnosis
of NPH or for selection of patients who will benefit from
shunting [27,28]. However, another study reported that
aqueductal SV in AD falls between the values recorded in
normal subjects and NPH patients and thus cannot be
used to differentiate between the two groups of patients
[43]. These contradictory results may be due to differ-
ences in the respective study populations. Our AD
patients were similar in terms of age and cognitive func-
tions to those in the aforementioned study. Although
cortical atrophy was not strictly calculated in our study,
it appeared to be mild (and thus similar to the volume
loss recorded in Bateman’s study). The major difference
concerns the aqueductal SV values in NPH patients,
which differed significantly between the two studies (70 ±
50 in Bateman’s study vs. 167 ± 89 in the present study).
Our results are similar to those published by Luetmer
et al. [35] in what was probably a highly selected popula-
tion. This may be due to different inclusion criteria; gait
disorders were mandatory in NPH patients in our study,
as this symptom is present in almost 80% of sufferers and
is the first of the triad sign to appear. All patients were
demented in Bateman’s study and gait disorders were
unnecessary if incontinence was present.
The difference in aqueductal SV between AD and
NPH patients is probably due to different etiological fac-
tors. AD is associated with amyloid deposits, which can
affect the small cerebral arteries and produce amyloid
angiopathy [40]. When combined with the greater pre-
valence of cardiovascular risk factors in AD patients
[15,38], amyloid angiopathy can increase the intrinsic
stiffness of the cerebral artery walls and cause failure of
the arterial pulse pressure dampening system. In AD, a
primary arterial wall pathology may be responsible for
greater outward brain expansion, compression of the
subarachnoid spaces and thus an increase in spinal cord
oscillations [21]. In contrast, it is thought (since publica-
tion of the “water hammer effect” theory by Greitz [34])
that the primary etiology in NPH first affects the subar-
achnoid space and then the arteries, with a reduction in
pulse pressure dampening.
Conclusion
This study has provided a novel vision of cerebral neurode-
generative disease. From a dynamic point of view, the brain
constantly interacts with the arterial blood inflow on one
hand and venous blood outflow and ventricular and subar-
achnoid CSF outflow on the other. PC-MRI is a novel way
of performing a rapid, non-invasive, reproducible evalua-
tion of these vascular and CSF flows and studying their
dynamic coupling throughout the cardiac cycle. This ima-
ging technique can be used to assist with differential diag-
noses in neurodegenerative disease. Our results suggest
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a-MCI and AD) may be initiated by an arterial inflow
increase, which is the prime factor underlying hydrody-
namic deregulation in these patients. In contrast, dramatic,
hyperdynamic disturbances of CSF flows were primarily
observed in NPH patients.
Additional material
Additional file 1: 3-D global animation of CSF and cerebral vascular
flows. This video of an NPH patient was created by merging PC-MRI
data sets with morphological MR images. It shows animated CSF/blood
flows through the aqueduct of Sylvius, the C2-C3 subarachnoid spaces,
the internal and vertebral carotid arteries and the jugular veins during
the cardiac cycle.
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